Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANTARES PHARMA, INC.

(ATRS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about ANTARES PHARMA, INC.
11/22Antares Pharma to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Confe..
GL
11/11Antaras pharma to present at the jefferies london health care conference
AQ
11/10Antares Pharma to Present at the Jefferies London Healthcare Conference
GL
11/04ANTARES PHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
11/04Antares Pharma Q3 Earnings Steady as Revenue Rises; Narrows Full-Year Sales Guidance --..
MT
11/04ANTARES PHARMA : Q3 Earnings Snapshot
AQ
11/04ANTARES PHARMA REPORTS THIRD QUARTER 2021 FINANCIAL AND OPERATING RESULTS - Form 8-K
PU
11/04Earnings Flash (ATRS) ANTARES PHARMA Posts Q3 Revenue $48.2M, vs. Street Est of $47.9M
MT
11/04ANTARES PHARMA, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
11/04Antares Pharma, Inc. Provides Financial Guidance for the Full Year 2021
CI
11/04Antares Pharma Reports Third Quarter 2021 Financial and Operating Results
GL
11/04Antares Pharma Reports Third Quarter 2021 Financial and Operating Results
GL
11/02ANTARES PHARMA, INC. : Entry into a Material Definitive Agreement, Financial Statements an..
AQ
11/02Antares Pharma, Inc. Enters into A Credit Agreement with Wells Fargo Bank in an Aggrega..
CI
10/28ANTARES PHARMA ANNOUNCES APPOINTMENT OF CARMEN VOLKART TO ITS BOARD OF DIRECTORS - Form..
PU
10/28ANTARES PHARMA, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/28Antares Pharma Announces Appointment of Carmen Volkart to its Board of Directors
GL
10/28Antares Pharma, Inc. Announces Appointment of Carmen Volkart to Its Board of Directors
CI
10/25ANTARES PHARMA : Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting of..
GL
10/25Antares Pharma Announces Oral Presentation at the 22nd Annual Fall Scientific Meeting o..
GL
10/21Antares Pharma to Report Third Quarter 2021 Financial and Operating Results
GL
10/21ANTARES PHARMA : to Report Third Quarter 2021 Financial and Operating Results
GL
10/19ANTARES PHARMA : Enters into exclusive license agreement with lipocine for tlando in u.s.
AQ
10/19LIPOCINE : And Antares Pharma Enter Into U.S. Licensing Agreement To Commercialize TLANDO
AQ
10/18LIPOCINE : Signs Deal with Antares Pharma for Commercialization of Tlando in the US; Share..
MT
10/18ANTARES PHARMA : Strikes Exclusive License Agreement For Oral Testosterone Replacement The..
MT
10/18ANTARES PHARMA : ENTERS INTO EXCLUSIVE LICENSE AGREEMENT WITH LIPOCINE FOR TLANDO« IN U.S ..
PU
10/18ANTARES PHARMA, INC. : Other Events (form 8-K)
AQ
10/18ANTARES PHARMA : Enters into Exclusive License Agreement With Lipocine for TLANDO« in U.S.
GL
10/18Antares Pharma Enters into Exclusive License Agreement with Lipocine for Tlando« in U.S
CI
09/30ANTARES PHARMA : Starts Phase 1 Study of ATRS-1902 Drug for Acute Adrenal Insufficiency Tr..
MT
09/30ANTARES PHARMA : Initiates Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
AQ
09/30Antares Pharma, Inc. Initiates Phase I Study for ATRS-1902 for Adrenal Crisis Rescue
CI
09/08ANTARES PHARMA : to Participate in the H.C. Wainright 23rd Annual Global Investment Confer..
PU
09/08Antares Pharma to Participate in the H.C. Wainwright 23rd Annual Global Investment Conf..
GL
08/18ANTARES PHARMA, INC. : Regulation FD Disclosure (form 8-K)
AQ
08/06Antares pharma reports second quarter 2021 financial and operating resultsewing
AQ
08/05ANTARES PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS O..
AQ
08/05Antares Pharma, Inc. Reaffirms Revenue Guidance for the Full Year 2021
CI
08/05ANTARES PHARMA : Q2 Earnings Snapshot
AQ
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Reports Q2 Revenue $45M, vs. Street ..
MT
08/05ANTARES PHARMA : Earnings Flash (ATRS) ANTARES PHARMA Posts Q2 EPS $0.03, vs. Street Est o..
MT
08/05ANTARES PHARMA : Reports Second Quarter 2021 Financial and Operating Results
AQ
08/05Antares Pharma, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 202..
CI
07/28Antares Pharma to Report Second Quarter 2021 Financial and Operating Results
GL
07/22ANTARES PHARMA : Gets US FDA OK to Start Trial of ATRS-1902 in Acute Adrenal Insufficiency
MT
07/22ANTARES PHARMA : Announces FDA Acceptance of IND Application for ATRS 1902 For Adrenal Cri..
PU
07/22Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Cr..
GL
07/22Antares Pharma, Inc Announces FDA Acceptance of IND Application for ATRS-1902 for Adren..
CI
07/16ANTARES PHARMA : Truist Securities Initiates Coverage on Antares Pharma With Buy Rating, $..
MT
07/09INSIDER TRENDS : Insider Disposition Eases Back 90-Day Buy Trend at Antares Pharma
MT
07/07Antares Pharma to Present at the Ladenburg Thalmann Annual Healthcare Conference
GL
06/28ANTARES PHARMA : ' Swiss Partner Idorsia Kicks Off Late-Stage Study for Selatogrel in Hear..
MT
06/28Antares Pharma Announces Partner Idorsia Initiates the Phase 3 Study With Selatogrel fo..
GL
06/28Idorsia to trial self-injection drug for heart attack victims
RE
06/25ANTARES PHARMA, INC.(NASDAQCM : ATRS) added to Russell 2000 Growth-Defensive Index
CI
06/25ANTARES PHARMA, INC.(NASDAQCM : ATRS) added to Russell 2000 Defensive Index
CI
06/22ANTARES PHARMA : Files Investigational New Drug Application With FDA for Early Stage Study..
MT
06/22Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis..
GL
06/22Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis..
CI
06/21ANTARES PHARMA, INC.(NASDAQCM : ATRS) dropped from S&P Healthcare Equipment Select Industr..
CI
06/21ANTARES PHARMA, INC.(NASDAQCM : ATRS) added to S&P Pharmaceuticals Select Industry Index
CI
06/15ANTARES PHARMA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/15Antares Pharma to Present at the Raymond James Human Health Innovations Conference
GL
06/14INSIDER TRENDS : Antares Pharma Insider Gets Stock Award, Buy Trend Intact
MT
06/14INSIDER TRENDS : Insider at Antares Pharma Receives Stock Award Uses Portion to Pay Taxes,..
MT
06/14INSIDER TRENDS : Antares Pharma Insider Granted Stock Award, Extends Buy Trend
MT
06/14INSIDER TRENDS : Antares Pharma Insider Receives Stock Award, Buy Trend Intact
MT
06/14INSIDER TRENDS : Antares Pharma Insider Receives Stock Award, Trend of Buys Extended
MT
06/14INSIDER TRENDS : Antares Pharma Insider Gets Stock Award, Prolongs Buy Trend
MT
06/14INSIDER TRENDS : Insider at Antares Pharma Receives Stock Award Uses Portion to Pay Taxes,..
MT
06/14INSIDER TRENDS : Antares Pharma Insider Receives Stock Award Uses Portion to Pay Taxes, Sl..
MT
06/10INSIDER TRENDS : Insider at Antares Pharma Disposes of Shares for Tax Slowing 90-Day Buy T..
MT
06/01ANTARES PHARMA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
05/26Antares Pharma to Present at the Jefferies Virtual Healthcare Conference
GL
1  2  3  4  5  6  7  8Next
Upcoming event on ANTARES PHARMA, INC.
03/08/22